Long-Term Effectiveness Study of Cystic Fibrosis Modulator Ivacaftor Reveals Real-World Outcomes

Long-Term Effectiveness Study of Cystic Fibrosis Modulator Ivacaftor Reveals Real-World Outcomes

On September 8, Erasmus MC Pedro Miranda Afonso published a paper in the Annals of the American Thoracic Society titled “Evaluating Long-Term Effectiveness of Cystic Fibrosis Modulator Therapies After Rapid Adoption: A Dual-Approach Study“, providing new important insights into the long-term effects of cystic fibrosis (CF) modulator therapies. This study focuses on the drug ivacaftor, … Read more

Persistent Pulmonary Fibrosis Changes in Severe COVID-19 Patients Three Years Later

Persistent Pulmonary Fibrosis Changes in Severe COVID-19 Patients Three Years Later

On July 1, Columbia University’s Christine Kim Garcia published a paper in the Ann Am Thorac Soc regarding post-COVID sequelae titled “Imaging, Pulmonary Function, and Histopathologic Findings of Persistent Fibrosis in a Longitudinal Cohort 3-Years after COVID-19.” This study systematically reveals the long-term evolution of pulmonary fibrosis caused by the coronavirus through a three-year follow-up … Read more